According to the statement released by Chinese scientists, a traditional Chinese medicine, named Kanglaite Injection has been approved by FDA.
The drug contains anticaner compounds extracted from the seed of coix and has been used as cancer treatment in China since 1995. It has been used to treat cancer and boost patients' immunity has been given the go-ahead for third phase of clinical trials in the US.
It has been used by more than 200000 patients and is among the best-selling cancer treatments in China.